CYTOKINETICS, INCORPORATED Operating Lease, Payments
CYTOKINETICS, INCORPORATED (CYTK) reported Operating Lease, Payments of $2.60 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2021-08-06
- CYTOKINETICS, INCORPORATED operating lease, payments for the quarter ending 2021-06-30 was $1.50M, a 6.25% decline year-over-year.
- CYTOKINETICS, INCORPORATED operating lease, payments for the quarter ending 2021-03-31 was $1.10M, a 45.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED operating lease, payments for the quarter ending 2020-12-31 was $1.50M, a 0.00% change year-over-year.
- CYTOKINETICS, INCORPORATED operating lease, payments for the quarter ending 2020-09-30 was $1.60M, a 33.33% increase year-over-year.
- CYTOKINETICS, INCORPORATED operating lease, payments for fiscal 2020 was $6.70M, a 34.00% increase from fiscal 2019.
- CYTOKINETICS, INCORPORATED operating lease, payments for fiscal 2019 was $5.00M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $2.60M 10-Q · filed 2021-08-06 | $4.10M derived: sum of 3 quarters · filed 2021-08-06 | $5.70M derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | $1.10M 10-Q · filed 2021-05-07 | $2.60M derived: sum of 2 quarters · filed 2021-05-07 | $4.20M derived: sum of 3 quarters · filed 2021-05-07 | $5.80M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.10M derived: sum of 2 quarters · filed 2021-02-26 | $4.70M derived: sum of 3 quarters · filed 2021-08-06 | $6.70M 10-K · filed 2021-02-26 |
| 2020-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.20M derived: sum of 2 quarters · filed 2021-08-06 | $5.20M 10-Q · filed 2020-11-06 | $6.70M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.60M 10-Q · filed 2021-08-06 | $5.10M derived: sum of 3 quarters · filed 2021-08-06 | $6.30M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-07 | $3.50M derived: sum of 2 quarters · filed 2021-05-07 | $4.70M derived: sum of 3 quarters · filed 2021-05-07 | $5.80M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.70M derived: sum of 2 quarters · filed 2021-02-26 | $3.80M derived: sum of 3 quarters · filed 2021-02-26 | $5.00M 10-K · filed 2021-02-26 |
| 2019-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $2.30M derived: sum of 2 quarters · filed 2020-11-06 | $3.50M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.30M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |